Zimmer Biomet Holdings Inc
NYSE:ZBH
Zimmer Biomet Holdings Inc
Cash from Operating Activities
Zimmer Biomet Holdings Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zimmer Biomet Holdings Inc
NYSE:ZBH
|
Cash from Operating Activities
$1.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
5%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
40%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Zimmer Biomet Holdings Inc's Cash from Operating Activities?
Cash from Operating Activities
1.6B
USD
Based on the financial report for Dec 31, 2023, Zimmer Biomet Holdings Inc's Cash from Operating Activities amounts to 1.6B USD.
What is Zimmer Biomet Holdings Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
5%
Over the last year, the Cash from Operating Activities growth was 23%. The average annual Cash from Operating Activities growth rates for Zimmer Biomet Holdings Inc have been 10% over the past three years , -2% over the past five years , and 5% over the past ten years .